Exchange of Azathioprine by Mycophenolatmofetile and Cyclosporine A Dose Reduction After Heart Transplantation
Status:
Completed
Trial end date:
2008-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to improve or save renal function by optimizing the
immunosuppressive regimen by reducing the Cyclosporine A dose and the exchange of
Azathioprine by Mycophenolatmofetile, which is an effective immunosuppressive agent and will
minimize the risk of acute rejection episodes.